Our adjusted MBR for the quarter, excluding the ACA payment, was 88.3% and in line with our expectations, representing an increase of 260 basis points compared to the prior year. The higher MBR was driven by COVID-19-related investments, testing and treatment costs, the divestiture of the P...
For our consumers and members impacted by COVID-19, we are providing them with continued access to quality healthcare while relieving some of the added costs and stress resulting from the pandemic. As previously announced, we waived co-pays for COVID-19 related diagnostic testing for all of o...